Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial

Christoph Kornauth, Tea Pemovska, PhDMSc,BSc, Gregory Ian Vladimer, PhD, Günther Bayer, Michael Bergmann, Sandra Eder, Ruth Eichner, Harald Esterbauer, MD PhD, Ruth Exner, Verena Felsleitner-Hauer, Maurizio Forte, MSc, Alexander Gaiger, Hildegard T. Greinix, MD, Wolfgang Gstöttner, Marcus Hacker, Alexander Hauswirth, MD, Tim Heinemann, Daniel Heintel, Mir Ali Reza Hoda, Ulrich Jaeger, Lukas Kazianka, MD, Lukas Kenner, MD, Barbara Kiesewetter, MD, Nikolaus Krall, PhD, Trang Le, BSc, Simone Lubowitzki, Marius E Mayerhoefer, Elisabeth Menschel, Olaf Merkel, PhD, Katsuhiro Miura, MD PhD, Leonhard Muellauer, MD PhD, Peter Neumeister, MD, Thomas Noesslinger, MD, Katharina Ocko, Leopold Öhler, Michael Panny, MD, Alexander Pichler, MD, Edit Anna Porpaczy, MD, Gerald Prager, MD, Markus Raderer, Robin Ristl, Reinhard Ruckser, MD, Julius Salamon, Ana-Iris Schiefer, Ann-Sofie Schmolke, MD, Ilse Schwarzinger, MD, Edgar Selzer, Cathrin Skrabs, Wolfgang R. Sperr, MD, Ismet Srndic, MSc, Renate Thalhammer, MD, Peter Valent, MD, Emiel van der Kouwe, PharmD, Katrina Vanura, PhD, Stefan Vogt, Cora Waldstein, Dominik Wolf, Univ. Prof. Dr., Christoph Zielinski, Ingrid Simonitsch-Klupp, MD, Giulio Superti-Furga, PhD, Berend Snijder, PhD, Philipp B. Staber, MD PhD

Blood (2020) 136 (Supplement 1): 2–4.

https://doi.org/10.1182/blood-2020-140831

Published: 2020

Journal Articles

Extracorporeal Photopheresis for First Line Treatment of Acute Graft Versus Host Disease

Florent Malard, MD PhD, Simona Sestili, MD, Sandra Eder, MD, Ramdane Belhocine, Annalisa Ruggeri, MD, Giorgia Battipaglia, MD, Eolia Brissot, MD PhD, Clemence Mediavilla, MD, Remy Dulery, MD, Mohamad Mohty, MD PhD

Blood (2018) 132 (Supplement 1): 2114.

https://doi.org/10.1182/blood-2018-99-114544

Published: 2018

Journal Articles

Efficacy and Feasibility of Sorafenib As a Maintenance Agent after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia

Blood (2016) 128 (22): 4624.

https://doi.org/10.1182/blood.V128.22.4624.4624

Published: 2016

Journal Articles

CD34+ Selected Cells "Boost" for Poor Graft Function Post Allogeneic Stem Cell Transplantation

Razan Mohty, Annalisa Ruggeri, MD, Giorgia Battipaglia, MD, Florent Malard, MD PhD, Eolia Brissot, MD, Ramdane Belhocine, Sandra Eder, MD, Federica Giannotti, MD, Remy Dulery, MD, Mohamad Mohty, MD PhD

Blood (2016) 128 (22): 2300.

https://doi.org/10.1182/blood.V128.22.2300.2300

Published: 2016

Journal Articles

Extracorporeal Photopheresis (ECP) for Acute Graft-Versus Host Disease (GvHD) after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

Sandra Eder, MD, Marie-Thérèse Rubio, MD PhD, Ramdane Belhocine, MD, Myriam Labopin, MD, Eolia Brissot, MDPhD, Anne-Claire Mamez, MD, Federica Giannotti, MD, Giorgia Battipaglia, MD, Annalisa Ruggeri, MD PhD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2015) 126 (23): 5466.

https://doi.org/10.1182/blood.V126.23.5466.5466

Published: 2015

Journal Articles

Thiotepa-Based Conditioning for Allogeneic Stem Cell Transplantation (allo-HSCT) in Acute Lymphoblastic Leukaemia (ALL) - a Survey from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Sandra Eder, MD, Eric Beohou, Myriam Labopin, MD, Jaime Sanz, MD, Jürgen Finke, MD, William Arcese, MD, Reuven Or, Francesca Bonifazi, Agostino Cortelezzi, MD, Ignazio Majolino, MD, Andrea Bacigalupo, MD, Alexandros Spyridonidis, Emilio Paolo Alessandrino, MD, Sebastian Giebel, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc

Blood (2015) 126 (23): 4316.

https://doi.org/10.1182/blood.V126.23.4316.4316

Published: 2015

Journal Articles

Safety and Efficacy of Thiotepa-Based Conditioning Therapy for Allogeneic Transplantation in Acute Myeloid Leukemia - a Survey from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Sandra Eder, MD, Myriam Labopin, MD, Jurgen Finke, MD, Donald W. Bunjes, MD, Attilio Olivieri, MD, Stella Santarone, MD, Alessandro Rambaldi, MD, Lothar Kanz, MD, Giuseppe Messina, MD, Arnon Nagler, MD, Mohamad Mohty

Blood (2014) 124 (21): 3895.

https://doi.org/10.1182/blood.V124.21.3895.3895

Published: 2014

Journal Articles

Thiotepa-Based Vs TBI-Based Myeloablative Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1): A Retrospective Analysis From The ALWP Of The EBMT

Sandra Eder, MD, Myriam Labopin, MD, William Arcese, MD, Reuven Or, MD, Ignazio Majolino, Andrea Bacigalupo, MD, Gennaro de Rosa, Liisa Volin, Dietrich Beelen, MD, Hendrik Veelken, MD PhD, Nicolaas PM Schaap, MD, PhD, Jurgen H Kuball, MD, PhD, Jan Cornelissen, MD, PhD, Arnon Nagler, MD, MSc, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 2123.

https://doi.org/10.1182/blood.V122.21.2123.2123

Published: 2013

Journal Articles

A New Prognostic Score for Aggressive B-Cell Lymphoma with C-MYC Translocation Integrating Clinical and Genetic Features.

Ana-Iris Schiefer, Michael Melcher, Zsuzsanna Bago-Horvath, Sandra Eder, Cathrin Skrabs, Alexander Hauswirth, Berthold Streubel, M.D., Christine Mannhalter, Dagmar Stoiber, Veronika Sexl, MD, Leonhard Müllauer, Ulrich Jaeger, MD, Edit Anna Porpaczy, MD

Blood (2012) 120 (21): 2685.

https://doi.org/10.1182/blood.V120.21.2685.2685

Published: 2012

Journal Articles

Induction Therapy with Novel Agents Improves Relapse-Free Survival After Autologous Stem-Cell Transplantation in Multiple Myeloma

Sandra Eder, Wolfgang Lamm, Michaela Gruber, Beatrice Schauer, Jutta Ackermann, Heinz Gisslinger, Johannes Drach

Blood (2011) 118 (21): 4494.

https://doi.org/10.1182/blood.V118.21.4494.4494

Published: 2011

Journal Articles

Bortezomib Administered Subcutaneously Is Well Tolerated in Bortezomib-Based Combination Regimens Used in Patients with Multiple Myeloma and AL Amyloidosis

Wolfgang Lamm, Beatrice Schauer, Sandra Eder, Christoph Zielinski, Johannes Drach

Blood (2011) 118 (21): 5124.

https://doi.org/10.1182/blood.V118.21.5124.5124

Published: 2011

Journal Articles

Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease–associated dysgammaglobulinemia

Zoya Kuzmina, Hildegard T. Greinix, Roman Weigl, Ulrike Körmöczi, Arno Rottal, Sophie Frantal, Sandra Eder, Winfried F. Pickl

Blood (2011) 117 (7): 2265–2274.

https://doi.org/10.1182/blood-2010-07-295766

Published: 2011

Includes: Supplemental data

Journal Articles

UDP Glucuronosyltransferase 2B17 Double Deletion Genotype Is An Independent Marker for Poor Prognosis In Multiple Myeloma

Michaela Gruber, Sandra Eder, Trang Le, Jutta Ackermann, Katrina Vanura, Ulrich Jaeger, Johannes Drach

Blood (2010) 116 (21): 2955.

https://doi.org/10.1182/blood.V116.21.2955.2955

Published: 2010

Journal Articles

Assessment of the Potential of Immature CD19+CD21- B-Lymphocytes to Predict Response to Various Systemic Therapies in Chronic Graft-Versus-Host Disease.

Zoya Kuzmina, Hildegard Greinix, Roman Weigl, Sandra Eder, Robert Knobler, Ulrike Koermoeczi, Arno Rottal, Christoph C Zielinski, Winfried F. Pickl

Blood (2009) 114 (22): 2226.

https://doi.org/10.1182/blood.V114.22.2226.2226

Published: 2009

NARROW

Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial

Extracorporeal Photopheresis for First Line Treatment of Acute Graft Versus Host Disease

Efficacy and Feasibility of Sorafenib As a Maintenance Agent after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia

CD34+ Selected Cells "Boost" for Poor Graft Function Post Allogeneic Stem Cell Transplantation

Extracorporeal Photopheresis (ECP) for Acute Graft-Versus Host Disease (GvHD) after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

Thiotepa-Based Conditioning for Allogeneic Stem Cell Transplantation (allo-HSCT) in Acute Lymphoblastic Leukaemia (ALL) - a Survey from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Safety and Efficacy of Thiotepa-Based Conditioning Therapy for Allogeneic Transplantation in Acute Myeloid Leukemia - a Survey from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Thiotepa-Based Vs TBI-Based Myeloablative Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1): A Retrospective Analysis From The ALWP Of The EBMT

A New Prognostic Score for Aggressive B-Cell Lymphoma with C-MYC Translocation Integrating Clinical and Genetic Features.

Induction Therapy with Novel Agents Improves Relapse-Free Survival After Autologous Stem-Cell Transplantation in Multiple Myeloma

Bortezomib Administered Subcutaneously Is Well Tolerated in Bortezomib-Based Combination Regimens Used in Patients with Multiple Myeloma and AL Amyloidosis

Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease–associated dysgammaglobulinemia

UDP Glucuronosyltransferase 2B17 Double Deletion Genotype Is An Independent Marker for Poor Prognosis In Multiple Myeloma

Assessment of the Potential of Immature CD19+CD21- B-Lymphocytes to Predict Response to Various Systemic Therapies in Chronic Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only